Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04449263 · ClinicalTrials.gov registry record · NA
Comparing the Performance of 1 Day Multifocal Contact Lenses
A NA study of Presbyopia, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 5
- Study locations
NCT04449263: Completed NA study of Presbyopia, sponsored by CooperVision.
NCT04449263 is a NA study of Presbyopia that has completed, run by CooperVision. The registered enrollment target is 60 participants, below the 269-participant average among 38 other Presbyopia trials with a reported enrollment target (78% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04449263, a NA study of Presbyopia, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 5
- Study locations
Study Summary
The objective of the study was to compare the lens handling and performance of Lens A to habitually worn multifocal contact lenses and to the competitor Lens B.
Primary Outcome
Subjective at-home ratings for ease of Lens handling for insertion will be assessed using a 0-10 scale, (0=very difficult, 10=very easy)
Conditions Studied
Interventions
- DEVICE Lens A
- DEVICE Lens B
- DEVICE Habitual Lenses
Study Locations (5)
California
- Scripps Poway Eyecare - San Diego
- Golden Optometric Group - Whittier
Florida
- Golden Vision - Sarasota
Kansas
- Kannarr Eye Care - Pittsburg
Ohio
- ProCare Vision Center - Granville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2020-07-27 |
| Est. Completion | 2020-12-30 |
| Phase | NA |
What the finished NCT04449263 record still lists
NCT04449263 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 269-participant average among 38 other Presbyopia trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Presbyopia appearing as the primary indexed condition, and to 3 interventions - of which Lens A is the first listed.
NCT04449263 lists 5 locations in 4 states (California, Florida, Kansas).
Frequently Asked Questions
What is clinical trial NCT04449263 about?
NCT04449263 is a clinical study titled "Comparing the Performance of 1 Day Multifocal Contact Lenses". The objective of the study was to compare the lens handling and performance of Lens A to habitually worn multifocal contact lenses and to the competitor Lens B.
What is the current status of trial NCT04449263?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2020-07-27. Estimated completion is 2020-12-30.
What conditions does trial NCT04449263 study?
This clinical trial studies the following conditions: Presbyopia.
What interventions are being tested in trial NCT04449263?
The interventions under investigation include: Lens A (DEVICE), Lens B (DEVICE), Habitual Lenses (DEVICE).
Who is sponsoring clinical trial NCT04449263?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04449263 being conducted?
This trial has 5 study locations across California, Florida, Kansas, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Presbyopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04449263's enrollment target sits among peer trials
60 25th of 38 higher than 14 of 38 other Presbyopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Presbyopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs
RECRUITING · NA
-
A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add
RECRUITING · NA
-
Presbyopic Wear Experience With Multifocal Lenses Compared to Single Vision Lenses and Reading Glasses
RECRUITING · NA
-
Clinical Applications of Advanced Ophthalmic Imaging
RECRUITING · NA
-
Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix
ACTIVE NOT RECRUITING · NA
-
Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI